Enlivex Therapeutics Stock Forward View
| ENLV Stock | USD 1.02 0.07 6.42% |
Enlivex Stock outlook is based on your current time horizon.
At this time, The relative strength indicator of Enlivex Therapeutics' share price is at 52 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Enlivex Therapeutics, making its price go up or down. Momentum 52
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.13) | EPS Estimate Current Year (0.40) | EPS Estimate Next Year (0.32) | Wall Street Target Price 13 | EPS Estimate Current Quarter (0.12) |
Using Enlivex Therapeutics hype-based prediction, you can estimate the value of Enlivex Therapeutics from the perspective of Enlivex Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Enlivex Therapeutics using Enlivex Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Enlivex using crowd psychology based on the activity and movement of Enlivex Therapeutics' stock price.
Enlivex Therapeutics Implied Volatility | 2.77 |
Enlivex Therapeutics' implied volatility exposes the market's sentiment of Enlivex Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Enlivex Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Enlivex Therapeutics stock will not fluctuate a lot when Enlivex Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Enlivex Therapeutics on the next trading day is expected to be 0.88 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 2.91. Enlivex Therapeutics after-hype prediction price | USD 1.21 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Enlivex Therapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Enlivex contract
Based on the Rule 16, the options market is currently suggesting that Enlivex Therapeutics will have an average daily up or down price movement of about 0.17% per day over the life of the 2026-05-15 option contract. With Enlivex Therapeutics trading at USD 1.02, that is roughly USD 0.001766 . If you think that the market is fully incorporating Enlivex Therapeutics' daily price movement you should consider acquiring Enlivex Therapeutics options at the current volatility level of 2.77%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-05-15 Enlivex Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Enlivex Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Enlivex Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Enlivex Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Enlivex Therapeutics' open interest, investors have to compare it to Enlivex Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Enlivex Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Enlivex. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Enlivex Therapeutics Additional Predictive Modules
Most predictive techniques to examine Enlivex price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Enlivex using various technical indicators. When you analyze Enlivex charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Enlivex Therapeutics' financial statements to predict how it will affect future prices.
Cash | First Reported 2013-12-31 | Previous Quarter 1.9 M | Current Value 4.2 M | Quarterly Volatility 13.2 M |
Enlivex Therapeutics Naive Prediction Price Forecast For the 5th of February
Given 90 days horizon, the Naive Prediction forecasted value of Enlivex Therapeutics on the next trading day is expected to be 0.88 with a mean absolute deviation of 0.05, mean absolute percentage error of 0, and the sum of the absolute errors of 2.91.Please note that although there have been many attempts to predict Enlivex Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Enlivex Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Enlivex Therapeutics Stock Forecast Pattern
| Backtest Enlivex Therapeutics | Enlivex Therapeutics Price Prediction | Research Analysis |
Enlivex Therapeutics Forecasted Value
In the context of forecasting Enlivex Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Enlivex Therapeutics' downside and upside margins for the forecasting period are 0.01 and 6.31, respectively. We have considered Enlivex Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Enlivex Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Enlivex Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 112.5293 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0477 |
| MAPE | Mean absolute percentage error | 0.0496 |
| SAE | Sum of the absolute errors | 2.9086 |
Predictive Modules for Enlivex Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Enlivex Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Enlivex Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Enlivex Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Enlivex Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Enlivex Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Enlivex Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Enlivex Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Enlivex Therapeutics' historical news coverage. Enlivex Therapeutics' after-hype downside and upside margins for the prediction period are 0.06 and 6.64, respectively. We have considered Enlivex Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Enlivex Therapeutics is risky at this time. Analysis and calculation of next after-hype price of Enlivex Therapeutics is based on 3 months time horizon.
Enlivex Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Enlivex Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Enlivex Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Enlivex Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.27 | 5.43 | 0.03 | 0.05 | 7 Events / Month | 6 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.02 | 1.21 | 11.01 |
|
Enlivex Therapeutics Hype Timeline
Enlivex Therapeutics is currently traded for 1.02. The entity has historical hype elasticity of -0.03, and average elasticity to hype of competition of -0.05. Enlivex is expected to increase in value after the next headline, with the price projected to jump to 1.21 or above. The average volatility of media hype impact on the company the price is over 100%. The price increase on the next news is projected to be 11.01%, whereas the daily expected return is currently at 0.27%. The volatility of related hype on Enlivex Therapeutics is about 3033.52%, with the expected price after the next announcement by competition of 0.97. Enlivex Therapeutics currently holds 534 K in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. Enlivex Therapeutics has a current ratio of 15.13, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Enlivex Therapeutics' use of debt, we should always consider it together with its cash and equity.Given the investment horizon of 90 days the next expected press release will be in about 7 days. Check out Historical Fundamental Analysis of Enlivex Therapeutics to cross-verify your projections.Enlivex Therapeutics Related Hype Analysis
Having access to credible news sources related to Enlivex Therapeutics' direct competition is more important than ever and may enhance your ability to predict Enlivex Therapeutics' future price movements. Getting to know how Enlivex Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Enlivex Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| CLGN | Collplant Biotechnologies | (0.02) | 5 per month | 0.00 | (0.06) | 8.51 | (8.38) | 26.83 | |
| LSTA | Lisata Therapeutics | 0.12 | 11 per month | 2.76 | 0.11 | 5.58 | (5.26) | 88.09 | |
| NCNA | NuCana PLC | (0.22) | 9 per month | 0.00 | (0.17) | 6.97 | (7.87) | 16.72 | |
| MTVA | MetaVia | (0.08) | 10 per month | 0.00 | (0.18) | 11.60 | (20.10) | 79.95 | |
| XCUR | Exicure | (1.02) | 9 per month | 8.47 | 0.03 | 21.22 | (11.88) | 63.80 | |
| CVKD | Cadrenal Therapeutics Common | (0.46) | 9 per month | 0.00 | (0.12) | 8.11 | (8.29) | 58.15 | |
| NRSN | Neurosense Therapeutics | 0.01 | 9 per month | 0.00 | (0.01) | 12.82 | (7.48) | 34.62 | |
| NRXS | Neuraxis | (0.01) | 9 per month | 4.34 | 0.11 | 7.88 | (7.62) | 38.80 | |
| GDTC | CytoMed Therapeutics Limited | (0.30) | 9 per month | 0.00 | (0.24) | 6.17 | (10.38) | 31.46 | |
| PASG | Passage Bio | 0.19 | 7 per month | 6.22 | 0.10 | 14.59 | (9.77) | 58.13 |
Other Forecasting Options for Enlivex Therapeutics
For every potential investor in Enlivex, whether a beginner or expert, Enlivex Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Enlivex Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Enlivex. Basic forecasting techniques help filter out the noise by identifying Enlivex Therapeutics' price trends.Enlivex Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Enlivex Therapeutics stock to make a market-neutral strategy. Peer analysis of Enlivex Therapeutics could also be used in its relative valuation, which is a method of valuing Enlivex Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Enlivex Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Enlivex Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Enlivex Therapeutics shares will generate the highest return on investment. By undertsting and applying Enlivex Therapeutics stock market strength indicators, traders can identify Enlivex Therapeutics entry and exit signals to maximize returns.
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 1.02 | |||
| Day Typical Price | 1.02 | |||
| Price Action Indicator | (0.04) | |||
| Period Momentum Indicator | (0.07) | |||
| Relative Strength Index | 52.54 |
Enlivex Therapeutics Risk Indicators
The analysis of Enlivex Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Enlivex Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting enlivex stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.97 | |||
| Semi Deviation | 4.34 | |||
| Standard Deviation | 5.2 | |||
| Variance | 27.03 | |||
| Downside Variance | 27.08 | |||
| Semi Variance | 18.79 | |||
| Expected Short fall | (5.40) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Enlivex Therapeutics
The number of cover stories for Enlivex Therapeutics depends on current market conditions and Enlivex Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Enlivex Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Enlivex Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Enlivex Therapeutics Short Properties
Enlivex Therapeutics' future price predictability will typically decrease when Enlivex Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Enlivex Therapeutics often depends not only on the future outlook of the potential Enlivex Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Enlivex Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.5 M | |
| Cash And Short Term Investments | 23.6 M |
Additional Tools for Enlivex Stock Analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.